Low concentrations of zinc in gastric mucosa are associated with increased severity of Helicobacter pylori-induced inflammation

Helicobacter

Volumn 12, Issue 1, 2007, Pages 43-48

  Sempértegui, Fernando ^a   Díaz, Myriam ^a   Mejía, Ricardo ^b   Rodríguez Mora, Oswaldo G ^a   Rentería, Edgar ^b   Guarderas, Carlos ^b   Estrella, Bertha ^a   Recalde, Ramiro ^b   Hamer, Davidson H ^c,d   Reeves, Philip G ^e  

^a Corporación Ecuatoriana de Biotecnología ^*  (Ecuador)

^b Hospital Pablo Arturo Suarez   (Ecuador)

^c BOSTON UNIVERSITY   (United States)

^d TUFTS UNIVERSITY   (United States)

^e GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Gastritis; Helicobacter pylori; Zinc

Indexed keywords

ZINC;

ADULT; AGED; ARTICLE; ATROPHY; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; DYSPEPSIA; ECUADOR; FEMALE; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH MUCOSA; TISSUE LEVEL; ZINC DEFICIENCY;

ADULT; AGED; BIOPSY; CHRONIC DISEASE; DYSPEPSIA; ECUADOR; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEUTROPHILS; ZINC;

HELICOBACTER PYLORI;

EID: 33846217312     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00476.x     Document Type: Article

References (38)

1. Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 2000;29:559-78.
2. Stoicov C, Saffari R, Cai X, Hasyagar C, Houghton J. Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling. Gene 2004;341:1-17.
3. Shang J, Pena AS. Multidisciplinary approach to understand the pathogenesis of gastric cancer. World J Gastroenterol 2005;11:4131-9.
4. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988;41:184-97.
5. Debets-Ossenkopp YJ, Reyes G, Mulder J, et al. Characteristics of clinical Helicobacter pylori strains from Ecuador. J Antimicrob Chemother 2003;51:141-5.
6. Cooke CL, Huff JL, Solnick JV. The role of genome diversity and immune evasion in persistent infection with Helicobacter pylori. FEMS Immunol Med Microbiol 2005;45:11-23.
7. Baldari CT, Lanzavecchia A, Telford JL. Immune subversion by Helicobacter pylori. Trends Immunol 2005;26:199-207.
8. Blaser MJ. The biology of cag in the Helicobacter pylori-human interaction. Gastroenterology 2005;128:1512-5.
9. Crabtree JE, Peichl P, Wyatt JI, Stachl U, Lindley IJ. Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand J Immunol 1993;37:65-70.
10. Brandt S, Kwok T, Hartig R, Konig W, Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA 2005;102:9300-5.
11. Peek RM Jr IV. Helicobacter pylori strain-specific activation of signal transduction cascades related to gastric inflammation. Am J Physiol Gastrointest Liver Physiol 2001;280:G525-30.
12. Dundon WG, Nishioka H, Polenghi A, et al. The neutrophil-activating protein of Helicobacter pylori. Int J Med Microbiol 2002;291:545-50.
13. Nielsen H, Andersen LP. Activation of human phagocyte oxidative metabolism by Helicobacter pylori. Gastroenterology 1992;103:1747-53.
14. Davies GR, Banatvala N, Collins CE, et al. Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 1994;29:419-24.
15. Davies GR, Simmonds NJ, Stevens TR, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994;35:179-85.
16. Broide E, Klinowski E, Varsano R, Eshchar J, Herbert M, Scapa E. Superoxide dismutase activity in Helicobacter pylori-positive antral gastritis in children. J Pediatr Gastroenterol Nutr 1996;23:609-13.
17. Gotz JM, van Kan CI, Verspaget HW, Biemond I, Lamers CB, Veenendaal RA. Gastric mucosal superoxide dismutases in Helicobacter pylori infection. Gut 1996;38:502-6.
18. Gotz JM, Thio JL, Verspaget HW, et al. Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases. Gut 1997;40:591-6.
19. Kountouras J, Chatzopoulos D, Zavos C. Reactive oxygen metabolites and upper gastrointestinal diseases. Hepatogastroenterology 2001;48:743-51.
20. Kawasaki K, Nishio A, Nakamura H, et al. Helicobacter felis-induced gastritis was suppressed in mice overexpressing thioredoxin-1. Lab Invest 2005.
21. Dreosti IE. Zinc and the gene. Mutat Res 2001;475:161-7.
22. Taylor CG, Bettger WJ, Bray TM. Effect of dietary zinc or copper deficiency on the primary free radical defense system in rats. J Nutr 1988;118:613-21.
23. Ho E, Ames BN. Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc Natl Acad Sci USA 2002;99:16770-5.
24. Sidhu P, Garg ML, Dhawan DK. Protective effects of zinc on oxidative stress enzymes in liver of protein-deficient rats. Drug Chem Toxicol 2005;28:211-30.
25. Ho E, Courtemanche C, Ames BN. Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts. J Nutr 2003;133:2543-8.
26. Ho E. Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem 2004;15:572-8.
27. Brussow H, Rytz A, Freire W, Rahim H, Dirren H. Risk factors associated with the recall of respiratory diseases in the Ecuadorian children. J Diarrhoeal Dis Res 1995;13:212-8.
28. Brussow H, Sidoti J, Dirren H, Freire WB. Effect of malnutrition in Ecuadorian children on titers of serum antibodies to various microbial antigens. Clin Diagn Lab Immunol 1995;2:62-8.
29. Hotz C, Brown KH. Assessment of the risk of zinc deficiency in populations. Food Nutr Bull 2004;25:S130-S162.
30. Dixon MF, Genta RM, Yardley JH, Correa P. Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter 1997;2 (Suppl. 1):S17-24.
31. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
32. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 2005;128:1567-78.
33. Hofman P, Waidner B, Hofman V, Bereswill S, Brest P, Kist M. Pathogenesis of Helicobacter pylori infection. Helicobacter 2004;9 (Suppl. 1):15-22.
34. Hotz C, Brown KH, International Zinc Nutrition Consultative Group (IZiNCG). Assessment of the Risk of Zinc Deficiency in Populations and Options for its Control. Food and Nutrition Bulletin (vol. 25). United Nations University Press, Tokyo, Japan, 2004; S91-2004.
35. Vaira D, Gatta L, Ricci C, Miglioli M. Review article: diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16 (Suppl. 1):16-23.
36. Suzuki H, Mori M, Seto K, et al. Polaprezinc attenuates the Helicobacter pylori-induced gastric mucosal leucocyte activation in Mongolian gerbils - a study using intravital videomicroscopy. Aliment Pharmacol Ther 2001;15:715-25.
37. Ishihara R, Iishi H, Sakai N, et al. Polaprezinc attenuates Helicobacter pylori-associated gastritis in Mongolian gerbils. Helicobacter 2002;7:384-9.
38. Kashimura H, Suzuki K, Hassan M, et al. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13:483-7.